Cargando…

Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study

BACKGROUND: Zinc supplementation was hypothesized to have therapeutic potential against prostate cancer, but its influence on prostate cancer incidence especially at high doses is controversial. METHODS: A total of 47,240 men from the Health Professionals Follow-up Study were followed from 1986 to 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yiwen, Song, Mingyang, Mucci, Lorelei A., Giovannucci, Edward L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630799/ https://www.ncbi.nlm.nih.gov/pubmed/36326979 http://dx.doi.org/10.1007/s10654-022-00922-0

Ejemplares similares

Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years
por: Plym, Anna, et al.
Publicado: (2022)

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
por: Watts, Eleanor L, et al.
Publicado: (2022)

Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia
por: Watts, Eleanor L., et al.
Publicado: (2022)

A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study
por: Dickerman, Barbra A., et al.
Publicado: (2020)

The association of diabetes with risk of prostate cancer defined by clinical and molecular features
por: Feng, Xiaoshuang, et al.
Publicado: (2020)

Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression
por: Graff, Rebecca E, et al.
Publicado: (2016)

ANO7 is associated with aggressive prostate cancer
por: Kaikkonen, Elina, et al.
Publicado: (2018)

Reduction in squamous cell carcinomas in mouse skin by dietary zinc supplementation
por: Sun, Jin, et al.
Publicado: (2016)

Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
por: Ma, Chaoran, et al.
Publicado: (2023)

Vitamin D deficiency and supplementation in patients with aggressive B‐cell lymphomas treated with immunochemotherapy
por: Hohaus, Stefan, et al.
Publicado: (2017)

Assessment of expression levels of leptin and leptin receptor as potential biomarkers for risk of prostate cancer development and aggressiveness
por: Kamel, Hala Fawzy Mohamed, et al.
Publicado: (2020)

Exploring Prostate Cancer Patients’ Interest and Preferences for Receiving Genetic Risk Information About Cancer Aggressiveness
por: Roy, Siddhartha, et al.
Publicado: (2020)

Prospective Implementation and Early Outcomes of a Risk-stratified Prostate Cancer Active Surveillance Follow-up Protocol
por: Thankapannair, Vineetha, et al.
Publicado: (2023)

A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer
por: Li, Haojie, et al.
Publicado: (2007)

Trajectories and risk factors for anxiety and depression in children and adolescents with cancer: A 1‐year follow‐up
por: Yardeni, Maya, et al.
Publicado: (2021)

Satisfaction with Nurse-led Follow-up in Prostate Cancer Patients—A Nationwide Population-based Study
por: Bergengren, Oskar, et al.
Publicado: (2022)

PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer
por: Barber, Alison G, et al.
Publicado: (2015)

Post-diagnostic health behaviour scores in relation to fatal prostate cancer
por: Graff, Rebecca E., et al.
Publicado: (2022)

Does Protocol Make a Difference? Comparison of Two Prostate Cancer Active Surveillance Cohorts: A Non–protocol-based Follow-up and a Protocol-based Contemporary Follow-up
por: Kalalahti, Inari, et al.
Publicado: (2021)

Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA‐life study
por: Stikbakke, Einar, et al.
Publicado: (2021)

Prediagnostic Plasma Vitamin D Metabolites and Mortality among Patients with Prostate Cancer
por: Fang, Fang, et al.
Publicado: (2011)

Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis
por: Kumar, Anurag, et al.
Publicado: (2022)

Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease
por: Walker, Simon R., et al.
Publicado: (2021)

Cancer Registry follow‐up for 17 million person‐years of a nationwide maternity cohort
por: Lehtinen, Matti, et al.
Publicado: (2017)

Low apolipoprotein A1 was associated with increased risk of cancer mortality in patients following percutaneous coronary intervention: A 10‐year follow‐up study
por: Nishiyama, Hiroki, et al.
Publicado: (2022)

Prostate cancer in Pennsylvania: The role of older age at diagnosis, aggressiveness, and environmental risk factors on treatment and mortality using data from the Pennsylvania Cancer Registry
por: Bluethmann, Shirley M., et al.
Publicado: (2020)

Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database
por: Beckmann, Kerri, et al.
Publicado: (2021)

Risk‐based breast cancer follow‐up stratified by age
por: Witteveen, Annemieke, et al.
Publicado: (2018)

Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case–control sets from EPIC
por: Schmidt, Julie A., et al.
Publicado: (2019)

Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis
por: Alpert, Evgenia, et al.
Publicado: (2021)

Genetic Polymorphisms of the Glycine N-Methyltransferase and Prostate Cancer Risk in the Health Professionals Follow-Up Study
por: Chen, Marcelo, et al.
Publicado: (2014)

Cancer risk and mortality after solid organ transplantation: A population‐based 30‐year cohort study in Finland
por: Friman, Terhi Kristiina, et al.
Publicado: (2022)

Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer
por: Julin, B, et al.
Publicado: (2015)

Cervical cancer testing among women aged 30–49 years in the WHO European Region
por: Williams, Julianne, et al.
Publicado: (2021)

Prostate Cancer Tumor Volume and Genomic Risk
por: Ramaswamy, Ashwin, et al.
Publicado: (2023)

Prognostic significance of prospectively detected bone marrow micrometastases in esophagogastric cancer: 10-year follow-up confirms prognostic significance
por: Ryan, Paul, et al.
Publicado: (2015)

Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience
por: Hagemans, J. A. W., et al.
Publicado: (2018)

High Serine-arginine Protein Kinase 1 Expression with PTEN Loss Defines Aggressive Phenotype of Prostate Cancer Associated with Lethal Outcome and Decreased Overall Survival
por: Abou-Ouf, Hatem, et al.
Publicado: (2020)

Giant aggressive forehead tumor: A 15-year follow-up
por: Challita, Raymond, et al.
Publicado: (2019)

Rotating night shift work and colorectal cancer risk in the nurses’ health studies
por: Papantoniou, Kyriaki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i56lehvjo00ekrfmkmp64p5bu1